lncRNA‑MALAT1 promotes high glucose‑induced H9C2 cardiomyocyte pyroptosis by downregulating miR‑141‑3p expression

Wu,Aishan; Sun,Weili; Mou,Fengying

doi:10.3892/mmr.2021.11898

lncRNA‑MALAT1 promotes high glucose‑induced H9C2 cardiomyocyte pyroptosis by downregulating miR‑141‑3p expression

Authors:
- Aishan Wu
- Weili Sun
- Fengying Mou
View Affiliations

Affiliations: Department of Cardiology II, Weihai Municipal Hospital, Weihai, Shandong 264200, P.R. China, Department of Anesthesiology, Weihai Municipal Hospital, Weihai, Shandong 264200, P.R. China, Department of Ultrasound, Weifang People's Hospital, Weifang, Shandong 261041, P.R. China
Published online on: February 8, 2021 https://doi.org/10.3892/mmr.2021.11898
Article Number: 259
Copyright: © Wu et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Diabetic cardiomyopathy (DCM) is caused by diabetes and can result in heart failure. Long non‑coding RNAs (lncRNAs) have been demonstrated to be closely associated with DCM development. The present study aimed to investigate whether lncRNA‑metastasis‑associated lung adenocarcinoma transcript‑1 (MALAT1) altered high glucose (HG)‑induced H9C2 cardiomyocyte pyroptosis by targeting microRNA (miR)‑141‑3p. H9C2 cells were treated with normal glucose (NG) or HG. lncRNA‑MALAT1 and miR‑141‑3p expression levels were determined via reverse transcription‑quantitative PCR (RT‑qPCR). MALAT1 and miR‑141‑3p knockdown and overexpression were established and confirmed via RT‑qPCR. The association between MALAT1 expression and miR‑141‑3p expression, as well as the induction of pyroptosis and gasdermin D (GSDMD)‑N expression were evaluated by performing dual luciferase reporter, TUNEL staining and immunofluorescence staining assays, respectively. Western blotting was conducted to measure the expression levels of pyroptosis‑associated proteins, including apoptosis‑associated speck‑like protein, GSDMD‑N, caspase‑1, nucleotide oligomerization domain‑like receptor protein 3 and GSDMD. MALAT1 mRNA expression levels were significantly increased, whereas miR‑141‑3p expression levels were significantly decreased in HG‑treated H9C2 cells compared with the NG group. Compared with the HG group, MALAT1 overexpression significantly reduced miR‑141‑3p expression levels, increased the rate of TUNEL positive cells and upregulated the expression levels of pyroptosis‑associated proteins. MALAT1 knockdown displayed the opposite effect on the rate of TUNEL positive cells and the expression levels of pyroptosis‑associated proteins. Furthermore, the rate of TUNEL positive cells, and GSDMD‑N and pyroptosis‑associated protein expression levels were significantly reduced by miR‑141‑3p overexpression in MALAT1‑overexpression H9C2 cells. The results indicated that compared with NG treatment, HG treatment increased MALAT1 expression levels and decreased miR‑141‑3p expression levels in H9C2 cells. Therefore, the present study suggested that lncRNA‑MALAT1 targeted miR‑141‑3p to promote HG‑induced H9C2 cardiomyocyte pyroptosis.

View Figures

View References

1	Lee WS and Kim J: Diabetic cardiomyopathy: Where we are and where we are going. Korean J Intern Med. 32:404–421. 2017. View Article : Google Scholar : PubMed/NCBI
2	Shen L, Li L, Li M, Wang W, Yin W, Liu W and Hu Y: Silencing of NOD2 protects against diabetic cardiomyopathy in a murine diabetes model. Int J Mol Med. 42:3017–3026. 2018.PubMed/NCBI
3	Wakisaka M, Kamouchi M and Kitazono T: Lessons from the trials for the desirable effects of sodium glucose Co-transporter 2 inhibitors on diabetic cardiovascular events and renal dysfunction. Int J Mol Sci. 20:56682019. View Article : Google Scholar
4	Hu X, Bai T, Xu Z, Liu Q, Zheng Y and Cai L: Pathophysiological fundamentals of diabetic cardiomyopathy. Compr Physiol. 7:693–711. 2017. View Article : Google Scholar : PubMed/NCBI
5	American, Diabetes, Association: 2. Classification and diagnosis of diabetes: Standards of medical care in diabetes-2019. Diabetes Care. 42 (Suppl 1):S13–S28. 2019. View Article : Google Scholar : PubMed/NCBI
6	Pasparakis M and Vandenabeele P: Necroptosis and its role in inflammation. Nature. 517:311–320. 2015. View Article : Google Scholar : PubMed/NCBI
7	Xu B, Jiang M, Chu Y, Wang W, Chen D, Li X, Zhang Z, Zhang D, Fan D, Nie Y, et al: Gasdermin D plays a key role as a pyroptosis executor of non-alcoholic steatohepatitis in humans and mice. J Hepatol. 68:773–782. 2018. View Article : Google Scholar : PubMed/NCBI
8	Shi J, Gao W and Shao F: Pyroptosis: Gasdermin-mediated programmed necrotic cell death. Trends Biochem Sci. 42:245–254. 2016. View Article : Google Scholar : PubMed/NCBI
9	Yue RC, Lu SZ, Luo Y, Wang T, Liang H, Zeng J, Liu J and Hu HX: Calpain silencing alleviates myocardial ischemia-reperfusion injury through the NLRP3/ASC/Caspase-1 axis in mice. Life Sci. 233:1166312019. View Article : Google Scholar : PubMed/NCBI
10	Biswas S, Thomas AA and Chakrabarti S: LncRNAs: Proverbial genomic ‘Junk’ or key epigenetic regulators during cardiac fibrosis in diabetes? Front Cardiovasc Med. 5:282018. View Article : Google Scholar : PubMed/NCBI
11	Asrih M and Steffens S: Emerging role of epigenetics and miRNA in diabetic cardiomyopathy. Cardiovasc Pathol. 22:117–125. 2013. View Article : Google Scholar : PubMed/NCBI
12	Zhang M, Gu H, Xu W and Zhou X: Down-regulation of lncRNA MALAT1 reduces cardiomyocyte apoptosis and improves left ventricular function in diabetic rats. Int J Cardiol. 203:214–216. 2016. View Article : Google Scholar : PubMed/NCBI
13	Ji P, Diederichs S, Wang W, Böing S, Metzger R, Schneider PM, Tidow N, Brandt B, Buerger H, Bulk E, et al: MALAT-1, a novel noncoding RNA, and thymosin beta4 predict metastasis and survival in early-stage non-small cell lung cancer. Oncogene. 22:8031–8041. 2003. View Article : Google Scholar : PubMed/NCBI
14	Michalik KM, You X, Manavski Y, Doddaballapur A, Zörnig M, Braun T, John D, Ponomareva Y, Chen W, Uchida S, et al: Long noncoding RNA MALAT1 regulates endothelial cell function and vessel growth. Circ Res. 114:1389–1397. 2014. View Article : Google Scholar : PubMed/NCBI
15	Qin Q, Cui L, Zhou Z, Zhang Z, Wang Y and Zhou C: Inhibition of microRNA-141-3p reduces hypoxia-induced apoptosis in H9c2 rat cardiomyocytes by activating the RP105-Dependent PI3K/AKT signaling pathway. Med Sci Monit. 25:7016–7025. 2019. View Article : Google Scholar : PubMed/NCBI
16	Yao B, Wan X, Zheng X, Zhong T, Hu J, Zhou Y, Qin A, Ma Y and Yin D: Critical roles of microRNA-141-3p and CHD8 in hypoxia/reoxygenation-induced cardiomyocyte apoptosis. Cell Biosci. 10:202020. View Article : Google Scholar : PubMed/NCBI
17	Gong D, Zhao ZW, Zhang Q, Yu XH, Wang G, Zou J, Zheng XL, Zhang DW, Yin WD and Tang CK: The long noncoding RNA metastasis-associated lung adenocarcinoma Transcript-1 Regulates CCDC80 expression by targeting miR-141-3p/miR-200a-3p in vascular smooth muscle cells. J Cardiovasc Pharmacol. 75:336–343. 2020. View Article : Google Scholar : PubMed/NCBI
18	Zhang J, Jiang T, Liang X, Shu S, Xiang X, Zhang W, Guo T, Xie W, Deng W and Tang X: lncRNA MALAT1 mediated high glucose-induced HK-2 cell epithelial-to-mesenchymal transition and injury. J Physiol Biochem. 75:443–452. 2019. View Article : Google Scholar : PubMed/NCBI
19	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
20	Ye Y, Zhang F, Chen Q, Huang Z and Li M: LncRNA MALAT1 modified progression of clear cell kidney carcinoma (KIRC) by regulation of miR-194-5p/ACVR2B signaling. Mol Carcinog. 58:279–292. 2019. View Article : Google Scholar : PubMed/NCBI
21	Xing Y, Jing H, Zhang Y, Suo J and Qian M: MicroRNA-141-3p affected proliferation, chemosensitivity, migration and invasion of colorectal cancer cells by targeting EGFR. Int J Biochem Cell Biol. 118:1056432020. View Article : Google Scholar : PubMed/NCBI
22	Adameova A and Dhalla NS: Role of microangiopathy in diabetic cardiomyopathy. Heart Fail Rev. 19:25–33. 2014. View Article : Google Scholar : PubMed/NCBI
23	Luo B, Li B, Wang W, Liu X, Liu X, Xia Y, Zhang C, Zhang Y, Zhang M and An F: Rosuvastatin alleviates diabetic cardiomyopathy by inhibiting NLRP3 inflammasome and MAPK pathways in a type 2 diabetes rat model. Cardiovasc Drugs Ther. 28:33–43. 2014. View Article : Google Scholar : PubMed/NCBI
24	Shi J, Zhao Y, Wang K, Shi X, Wang Y, Huang H, Zhuang Y, Cai T, Wang F and Shao F: Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death. Nature. 526:660–665. 2015. View Article : Google Scholar : PubMed/NCBI
25	Fann DY, Lee SY, Manzanero S, Tang SC, Gelderblom M, Chunduri P, Bernreuther C, Glatzel M, Cheng YL, Thundyil J, et al: Intravenous immunoglobulin suppresses NLRP1 and NLRP3 inflammasome-mediated neuronal death in ischemic stroke. Cell Death Dis. 4:e7902013. View Article : Google Scholar : PubMed/NCBI
26	Feng Y, Xu W, Zhang W, Wang W, Liu T and Zhou X: LncRNA DCRF regulates cardiomyocyte autophagy by targeting miR-551b-5p in diabetic cardiomyopathy. Theranostics. 9:4558–4566. 2019. View Article : Google Scholar : PubMed/NCBI
27	Taylor DH, Chu ET, Spektor R and Soloway PD: Long non-coding RNA regulation of reproduction and development. Mol Reprod Dev. 82:932–956. 2015. View Article : Google Scholar : PubMed/NCBI